Trial Profile

Flucelvax Pregnancy Registry: an Observational Study on the Safety of Flucelvax Exposure in Pregnant Women and Their Offspring

Status: Withdrawn prior to enrolment

Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Influenza vaccine (Optaflu) (Primary)
Indications Influenza virus infections
Focus Adverse reactions
Sponsors Novartis; Seqirus

Most Recent Events

09 Aug 2016 Status changed from recruiting to withdrawn prior to enrolment.
22 Dec 2014 Planned End Date changed from 1 Dec 2020 to 1 Jun 2020 according to ClinicalTrials.gov.
22 Dec 2014 Planned primary completion date changed from 1 Dec 2020 to 1 Jun 2020 according to ClinicalTrials.gov

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com